Recent research of Biotechnology and Genomics signifies the advancement of biomarkers to detect individual disease risk and enhance diagnostic classification to better inform personalized treatment. The identification and development of biomarkers for personalized, preventive and predictive medicine was a major impulse of Human Genome Project.
Biomarkers related to Genomics measure changes in the quantity or nature of nucleic acids . DNA-based biomarkers include copy number variation, mutations(including polymorphisms, somatic mutations, and other genetic variants), and epigenetic modifications. RNA expression-based biomarkers include quantification of mRNA, microRNA and long noncoding RNA expression.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations:The Genome consortium for active teaching, American Society for Human Genetics, American Society for Gene therapy, European Molecular Biology laboratory.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
